RTALB Stock Overview
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₺15.21 |
| 52 Week High | ₺32.56 |
| 52 Week Low | ₺10.45 |
| Beta | 0.11 |
| 1 Month Change | -3.24% |
| 3 Month Change | -11.67% |
| 1 Year Change | -5.65% |
| 3 Year Change | 71.00% |
| 5 Year Change | 1,466.22% |
| Change since IPO | 1,060.55% |
Recent News & Updates
Recent updates
Shareholder Returns
| RTALB | TR Biotechs | TR Market | |
|---|---|---|---|
| 7D | -1.2% | -2.8% | -3.4% |
| 1Y | -5.6% | -5.7% | 24.2% |
Return vs Industry: RTALB matched the TR Biotechs industry which returned -5.7% over the past year.
Return vs Market: RTALB underperformed the TR Market which returned 24.2% over the past year.
Price Volatility
| RTALB volatility | |
|---|---|
| RTALB Average Weekly Movement | 9.1% |
| Biotechs Industry Average Movement | 8.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in TR Market | 8.8% |
| 10% least volatile stocks in TR Market | 4.5% |
Stable Share Price: RTALB's share price has been volatile over the past 3 months compared to the TR market.
Volatility Over Time: RTALB's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of TR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 69 | Resat Ultav | www.rtalabs.com.tr |
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers microbiology products, including petri dish, tube and bottle, chromogenic media, blood culture bottle, tuberculosis diagnostic, rapid test, microbiological stain, hygislide, surcheck media, membrane, and swab products; and molecular biology products, such as nucleic acid isolation kits, real time PCR kits, and voltran viral load detection systems. The company was incorporated in 1996 and is based in Kocaeli, Turkey.
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. Fundamentals Summary
| RTALB fundamental statistics | |
|---|---|
| Market cap | ₺1.52b |
| Earnings (TTM) | -₺170.71m |
| Revenue (TTM) | ₺118.40m |
12.8x
P/S Ratio-8.9x
P/E RatioIs RTALB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RTALB income statement (TTM) | |
|---|---|
| Revenue | ₺118.40m |
| Cost of Revenue | ₺92.65m |
| Gross Profit | ₺25.75m |
| Other Expenses | ₺196.46m |
| Earnings | -₺170.71m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.71 |
| Gross Margin | 21.75% |
| Net Profit Margin | -144.19% |
| Debt/Equity Ratio | 11.1% |
How did RTALB perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 07:49 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|